Endospan - Transforming Treatment of Life-Threatening Aortic Arch Disease

About Endospan

 

Endospan brings together a seasoned team of researchers, engineers and executives in the MedTech field. Backed by leading global venture groups, Endospan is focused on becoming a dominant competitor in the endovascular aortic repair market.

The Endospan platform is innovative, opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The novel design of Endospan’s systems presents a true advancement when compared to traditional EVAR/TEVAR systems, enhancing endografts with gold-standard material durability, intra-procedural stability, and a shorter, simpler and less-invasive procedure.

Click here for our Company Fact Sheet

Our Leadership

Kevin Mayberry

Chief Executive Officer


Pieter Buyl
Vice President, Sales and Marketing

Ami Katz

Vice President, Operations

Jessica Kleine

Vice President, Clinical Affairs

Mario Lachat

Medical Director


Ian McDougall

Vice President, Research & Development


David Planer

Medical Director

Noa Weinstein

Chief Financial Officer

Kevin Mayberry, CEO

Click here for Profile

Maskit St. 4  Herzlia Business Park, Herzlia, ISRAEL 46733

CAUTION: Endospan devices bear the CE marking of conformity. Not available for sale in the United States.

  • LinkedIn
  • Facebook Social Icon

© 2019 by Endospan Ltd.   Last update September 17, 2019